Q-omics provides the consensus-scored MTND4LP20 profile across patient tissues and cancer cell-line models. MTND4LP20 expression is associated with patient survival in 7 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, MTND4LP20 RNA expression shows 2,523 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where MTND4LP20 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for MTND4LP20 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes MTND4LP20 survival associations across molecular data types. MTND4LP20 RNA expression shows survival associations in the most cancer types (7). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

MTND4LP20 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	7	STAD (51)	view →

This table ranks reproducible MTND4LP20 RNA expression–survival associations across cancer types. High MTND4LP20 expression shows unfavorable associations in STAD, KIRC, LUAD, LGG, SKCM and LIHC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .007). Together, the overview and detailed table identify STAD as the clearest survival context for MTND4LP20 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.513	0.674	.007	51	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
LUAD	OS	Tertile	All	0.224	0.697	.027	18	view →
LGG	OS	Tertile	All	0.667	0.897	.017	18	view →
SKCM	DFS	Tertile	All	0.306	0.642	.023	9	view →
LIHC	OS	Tertile	II,III,IV	0.284	0.637	.042	9	view →

Pink = unfavorable, green = favorable. all 7 lineages →

MTND4LP20-STAD (DFS)

Kaplan–Meier survival curve for MTND4LP20 RNA expression in STAD: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with MTND4LP20 in patient tissues and cancer cell lines. In patient samples, MTND4LP20 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	2,523	STAD (2229)	view →
RNA	2,465	UCEC (1558)	view →